薛定谔公司
估值 各估值倍数与自身5年区间的对比
同业对比 Health Information Services
| 公司 | 市值 | 市盈率(TTM)i | 市净率i | 股息率i |
|---|---|---|---|---|
| 薛定谔公司 (SDGR) | 1.69B | -30.96 | 5.14 | 0.00% |
| Veeva Systems (VEEV) | 50.25B | 50.88 | 6.76 | 0.00% |
| BrightSpring Health Services (BTSG) | 12.04B | 36.89 | 5.88 | 0.00% |
| Tempus AI (TEM) | 11.68B | -44.94 | 26.24 | 0.00% |
| Hinge Health (HNGE) | 8.00B | 74.11 | 23.24 | 0.00% |
| HealthEquity (HQY) | 7.61B | 33.22 | 3.83 | 0.00% |
StockVane 追踪范围内同行业的其他公司。
Morningstar
当前股价低于晨星合理价值估算110.2%。
合理价值
Schrodinger Inc earns a 4-star quantitative star rating, indicating our belief that this share class offers a somewhat attractive opportunity for investors. The stock currently trades at a 31% discount to our quantitative fair value estimate of $47.50 per share; however, caution is warranted due to this estimate's very high uncertainty rating.
The company's liquidity bolsters our fair value estimate. Adequate liquidity allows a company to meet short-term obligations, enhancing financial stability and reducing distress risk. For example, the firm's median trading volume over the past 60 days falls in the top 30% compared with peers globally. Trading volumes are high on shares, which may indicate increased institutional interest in stock ownership. We believe this is a sign that shares could be undervalued.
Alternatively, the company's lack of profitability is potentially concerning. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. The firm's earnings yield of -4.2%, a core component of profitability, lies in the bottom 20% compared with peers globally. The earnings generated by the company relative to its share price is concerning, which, despite our favorable price/fair value ratio, is a negative attribute.
In addition to the aforementioned drivers, our model considers momentum as part of its comprehensive analysis. This share class has been a laggard relative to the broader universe over the past year. This underperformance makes the stock appear cheap, which portends a buying opportunity in light of other contributors to our model.
经济护城河
The company's quantitative economic moat rating of none suggests any excess returns could erode quickly as competition arrives. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.
作者:Quantitative Equity Report
报价时间 2026-10-16 19:54:49 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
薛定谔公司 讨论区 0 条评论